Pain is the primary symptom in a range of health conditions. Poorly managed acute or chronic pain may negatively influence numerous aspects of a person’s life. However, managing pain adequately remains a challenge in many conditions1.
For mild to moderate pains, NSAIDs (non-steroidal anti-inflammatory drugs) remain the mainstay of treatment. NSAIDs like ibuprofen have some distinct benefits like they are readily available. In addition, they do not cause dependence. However, they might often fail in moderate to severe pain requiring combination drug therapy2.
In moderate to severe pain, synthetic drugs like Tramadol and Tapentadol may provide excellent relief. These are synthetic analogues of morphine with a considerably improved safety profile. It means that they can be readily prescribed for various painful conditions, infrequently cause side effects, and rarely cause any dependence.
However, it is worth knowing that sometimes these medications may work better when combined with NSAIDs. It is because, unlike NSAIDs, they do not have anti-inflammatory properties. These drugs are primarily painkillers.
Although Tapentadol and Tramadol share many traits, with quite a similar mode of action, they differ considerably in pharmacokinetics (how the body processes drugs) and pharmacodynamics (mechanism of action).
Tapentadol vs Tramadol – Pharmacokinetics
Although they may have similar effective dosages in many conditions, and both are commonly available as 50 mg tablets. Still, there are many differences between the two.
First and foremost, tramadol works mainly through active metabolites, and tapentadol is directly active. It means that tapentadol starts working as soon as it reaches the bloodstream, with a reliable mode of action. However, tramadol is first metabolized into active metabolites, with different modes of action. These metabolites of tramadol are more potent than the parent molecule. Since tramadol needs to be metabolized, it generally has a delayed onset of action and less reliable effect in some individuals3.
The second significant difference between the two is that tramadol is dependent on the enzyme CYP2D6 for conversion into active metabolites. Its two major active metabolites are (+) and (-) enantiomers. These two enantiomers have a different modes of action4. In practice, it means that those deficient in these enzymes may not get sufficient benefit from the drug. Studies show that about 6% of Caucasians may be deficient in this enzyme5.
Both drugs are effective from 50 mg onwards. However, unlike Tapentadol, Tramadol may need a loading dosage (starting dose) of 100 mg, followed by 50 mg every 6 hours, or as required. These differences are mainly due to differences between the two in pharmacokinetics5,6.
Ultimately, both the drugs are metabolized in the liver, and their inactive metabolites are excreted via kidneys. Generally, mild to moderate kidney or liver disease does not affect their metabolism. However, those living with severe kidney or liver disease may need dosage correction.
Tapentadol vs Tramadol – Pharmacodynamics
Both these medications share numerous traits with morphine. However, these drugs were created as effective and yet much safer analogues of morphine. Although both the drugs work by influencing opioid receptors (especially mu-opioid receptors or MOR), there is a difference3. Activation of MOR receptors results in the potent painkilling effect of opioids.
It is a MOR activator and powerful Noradrenaline (NA) and 5HT (serotonin) reuptake inhibition. As it is metabolized to (+) and (-) enantiomers, it is worth knowing that its (+) enantiomer has more potent action on MOR receptors, causing higher pain relief. Unfortunately, it also means that tramadol has poor efficacy in those deficient in CYP2D6 enzyme, which may be close to 6% of the European population7.
Studies show that most of its actions are due to its effects on MOR receptors and inhibition of NA uptake, with 5HT inhibition playing a minor role7.
Quite like tramadol, it affects MOR receptors and inhibits NA receptors. However, unlike tramadol, it does not influence 5HT. Moreover, tapentadol is not a prodrug. Thus, it starts acting soon after absorption by the body. It is not dependent on liver enzymes for conversion to active forms8.
As tapentadol’s affinity to MOR receptors differs from tramadol, further lack of action on 5HT means it differs in efficacy and safety.
Studies show that tapentadol (Aspadol 100mg) has a more significant influence on MOR (that is, opioid) receptors than NA inhibition. Therefore, it appears to be a more potent central acting pain killer than tramadol. Some experts think it is 2-3 times more potent than tramadol, though it is less potent and safer than morphine9.
Tapentadol vs Tramadol – Toxicology
Both Tapentadol and Tramadol were created as a safer alternative to morphine. Morphine is more potent than both these drugs, but it causes numerous side effects characteristic of opioids like dry mouth, constipation, vomiting, nausea, sedation, respiratory depression, addiction10. Tapentadol and tramadol are much safer alternatives.
Tapentadol is much more potent than tramadol. It is because it has a greater influence on opioid receptors than tramadol. However, it also means greater chances of opioid-like side effects (but much milder and transient) like drowsiness, constipation, respiratory depression. But it also means that tapentadol has fewer chances of side effects associated with the serotonergic activity of tramadol like vomiting and nausea9,11.
How does Tapentadol Compare to Tramadol?
To conclude, it appears that tapentadol has the edge over tramadol. It is more effective in many ways12.
|Opioid activity||Higher opioid activity||Moderate action||Greater painkilling effect|
|Other actions||NA reuptake inhibition, no action on 5HT||NA and 5HT reuptake inhibitor||Fewer side effects related to serotonergic activity|
|Role of metabolites||Active drug||Mainly prodrug||Faster onset and reliable effect of tapentadol|
|Onset of action||32 min||Within 60 min||Faster action|
|Drug interactions||No effect on CYP450 enzymes||Metabolized by CYP450 enzymes||Greater chances of tramadol’s interaction with other drugs|
|Variation of action||Not dependent on CYP pathway||Dependent of activity of CYP pathway||Less effective in individuals who are genetically deficient in these enzymes|
Table 1 Adapted from; Singh DR, Nag K, Shetti AN, Krishnaveni N. Tapentadol hydrochloride: A novel analgesic. Saudi J Anaesth. 2013;7(3):322-326. doi:10.4103/1658-354X.115319)
As is evident from Table 1 that tapentadol is better than tramadol in some ways. Nonetheless, it is worth noticing that tapentadol, though more effective than tramadol, is not essentially safer as it is more probable to cause side effects related to its higher opioid activity.
Read About :- Soma vs Tramadol
- Sinatra R. Causes and Consequences of Inadequate Management of Acute Pain. Pain Medicine. 2010;11(12):1859-1871. doi:10.1111/j.1526-4637.2010.00983.x
- Blondell RD, Azadfard M, Wisniewski AM. Pharmacologic Therapy for Acute Pain. AFP. 2013;87(11):766-772.
- Giorgi M. Tramadol Vs Tapentadol: Anew Horizon in Pain Treatment? American Journal of Animal and Veterinary Sciences. 2012;7:7-11.
- Grond S, Sablotzki A. Clinical Pharmacology of Tramadol. Clin Pharmacokinet. 2004;43(13):879-923. doi:10.2165/00003088-200443130-00004
- Tramadol Hydrochloride 50mg Capsules – Summary of Product Characteristics (SmPC) – (emc). Published October 8, 2021. Accessed August 23, 2021. https://www.medicines.org.uk/emc/product/5924/smpc#gref